Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,005,833
-
Share change
-
+1,992,949
-
Total reported value
-
$51,492,347
-
Price per share
-
$6.43
-
Number of holders
-
49
-
Value change
-
+$12,947,405
-
Number of buys
-
37
-
Number of sells
-
8
Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM NEW as of Q2 2020
As of 30 Jun 2020,
CATABASIS PHARMACEUTICALS IN - COM NEW was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,005,833 shares.
The largest 10 holders included
FEDERATED HERMES, INC., BlackRock Inc., VANGUARD GROUP INC, Samsara BioCapital, LLC, SV Health Investors, LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Blackstone Group Inc, and Parkman Healthcare Partners LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.